市场见解

Here’s why the Race Oncology (ASX:RAC) share price is climbing today

Why is Race Oncology making the heart tick today?
The post Here’s why the Race Oncology (ASX:RAC) share price is climbing today appeared first on The Motley Fool Australia. –

The Race Oncology Ltd (ASX: RAC) share price is rising today after the company announced positive findings on its anti-cancer drug trials.

At the time of writing, Race Oncology shares are in the green, up 4.47% trading at $3.27.

Race Oncology is a Sydney-based company working on clinical development and commercialisation of the anti-cancer drug Zantrene.

What did the company announce today?

Race Oncology is investigating if Zantrene can protect the heart from damage by other drugs.

In today’s release, the company said preclinical studies showed that Zantrene was able to “protect heart muscle cells from a new class of anti-cancer drug (Carfilzomib)-induced cell death” while also improving its ability to kill cancer cells.

Race advised it has submitted a patent application “addressing the combination of Zantrene with carfilzomib for the protection of the heart of cancer patients”. If granted, the patent would cover the clinical use of the drug combination until 2041, it said.

The company added that its findings opened up a potential for collaboration with other companies. Carfilzomib is owned by US pharmaceutical giant Amgen, Inc.

Race Oncology advised its next steps included conducting animal studies early next year and performing more preclinical studies on other anti-cancer drugs.

What did management say?

Speaking about the news potentially driving the Race Oncology share price today, CEO Phillip Lynch said:

This additional result further underscores the potential patient utility and commercial applicability for Zantrene.

We will be allocating additional resources to ensure this discovery can be comprehensively addressed.

Race Oncology share price snapshot

The Race Oncology share price has surged this year to date, up 86%. It is also up almost 55% over the past 12 months.

For comparison, the benchmark All Ordinaries Index (ASX: XAO) is up nearly 11% over the last year.

The yearly high for the share price is $4.23, while the yearly low was $1.62.

Based on its current price of $3.27, Race Oncology has a market capitalisation of around $489 million.

The post Here’s why the Race Oncology (ASX:RAC) share price is climbing today appeared first on The Motley Fool Australia.

Should you invest $1,000 in Race Oncology right now?

Before you consider Race Oncology , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Race Oncology wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why is the Race Oncology (ASX:RAC) share price plunging 12% today?

Why Bapcor, Mayne Pharma, Race Oncology, and TechnologyOne shares are sinking

Racing higher: Race Oncology (ASX:RAC) share price jumps 13% on study breakthrough

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!